Financials GMO Research & AI, Inc.

Equities

3695

JP3386530004

Advertising & Marketing

Market Closed - Japan Exchange 10:29:56 2024-05-20 pm EDT 5-day change 1st Jan Change
2,745 JPY +0.29% Intraday chart for GMO Research & AI, Inc. -1.44% -2.03%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,303 3,010 2,715 3,655 5,491 4,575
Enterprise Value (EV) 1 1,448 2,306 1,814 2,409 4,340 3,252
P/E ratio 15.6 x 22.1 x 15.5 x 13.3 x 15.4 x 14.9 x
Yield 3.21% 2.28% 3.23% 3.75% 3.24% 4.1%
Capitalization / Revenue 0.72 x 0.91 x 0.8 x 0.89 x 1.06 x 0.89 x
EV / Revenue 0.45 x 0.7 x 0.53 x 0.59 x 0.83 x 0.64 x
EV / EBITDA 4.08 x 7.69 x 5.45 x 5.72 x 8.59 x 6.14 x
EV / FCF 12.3 x 16.6 x 7.02 x 6.06 x -113 x 10.6 x
FCF Yield 8.15% 6.03% 14.2% 16.5% -0.89% 9.43%
Price to Book 1.7 x 2.18 x 1.83 x 2.18 x 2.88 x 2.24 x
Nbr of stocks (in thousands) 1,657 1,629 1,631 1,632 1,632 1,633
Reference price 2 1,390 1,847 1,665 2,240 3,365 2,802
Announcement Date 3/19/19 3/23/20 3/22/21 3/22/22 3/23/23 3/19/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3,186 3,290 3,394 4,086 5,200 5,117
EBITDA 1 355 300 333 421 505 530
EBIT 1 249 213 263 353 420 441
Operating Margin 7.82% 6.47% 7.75% 8.64% 8.08% 8.62%
Earnings before Tax (EBT) 1 211 201 239 385 457 427
Net income 1 148 137 175 274 356 307
Net margin 4.65% 4.16% 5.16% 6.71% 6.85% 6%
EPS 2 89.13 83.74 107.3 167.9 218.2 188.0
Free Cash Flow 1 118 139.1 258.4 397.6 -38.5 306.6
FCF margin 3.7% 4.23% 7.61% 9.73% -0.74% 5.99%
FCF Conversion (EBITDA) 33.24% 46.38% 77.59% 94.45% - 57.85%
FCF Conversion (Net income) 79.73% 101.55% 147.64% 145.12% - 99.88%
Dividend per Share 2 44.65 42.11 53.86 83.97 109.1 114.8
Announcement Date 3/19/19 3/23/20 3/22/21 3/22/22 3/23/23 3/19/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2022 Q1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1
Net sales 1 1,612 1,865 1,365 2,551 1,220 1,427 2,581 1,220 1,361
EBITDA - - - - - - - - -
EBIT 1 33 152 210 263 81 198 204 99 119
Operating Margin 2.05% 8.15% 15.38% 10.31% 6.64% 13.88% 7.9% 8.11% 8.74%
Earnings before Tax (EBT) 1 15 173 231 326 104 191 220 91 122
Net income 1 13 128 175 246 72 135 154 63 92
Net margin 0.81% 6.86% 12.82% 9.64% 5.9% 9.46% 5.97% 5.16% 6.76%
EPS 2 8.560 78.64 107.8 151.0 43.98 83.23 94.91 38.13 56.49
Dividend per Share 2 - - - - - - - - -
Announcement Date 8/7/20 8/6/21 5/9/22 8/4/22 11/7/22 5/8/23 8/3/23 11/6/23 5/8/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 855 704 901 1,246 1,151 1,323
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 118 139 258 398 -38.5 307
ROE (net income / shareholders' equity) 10.9% 10% 12.2% 17.3% 19.9% 15.5%
ROA (Net income/ Total Assets) 7.67% 6.42% 7.62% 8.77% 8.94% 9.09%
Assets 1 1,929 2,135 2,296 3,123 3,981 3,378
Book Value Per Share 2 820.0 846.0 910.0 1,027 1,169 1,252
Cash Flow per Share 2 266.0 293.0 407.0 407.0 470.0 541.0
Capex 1 4 1 1 10 3 -
Capex / Sales 0.13% 0.03% 0.03% 0.24% 0.06% -
Announcement Date 3/19/19 3/23/20 3/22/21 3/22/22 3/23/23 3/19/24
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 3695 Stock
  4. Financials GMO Research & AI, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW